GGrantIndex
← Search

Pediatric Formulations of Select Second Line Drugs for Treating Tuberculosis

$299,995N43FY2021AINIH

Via Therapeutics, Llc, Austin TX

Investigators

Abstract

TO DEVELOP LOW-COST, SHELF-STABLE, PATIENT- ADAPTABLE MINI-TABLETS FOR TREATMENT OF TUBERCULOSIS IN PEDIATRICS

View original record on NIH RePORTER →